Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pethidine, also known as meperidine, is a fully synthetic opioid analgesic of the phenylpiperidine class. It primarily acts as an agonist at the μ-opioid receptor to provide analgesia for moderate to severe pain. Its onset of action is faster and its duration shorter than morphine. Besides its primary use in acute pain management—including postoperative and labor pain—pethidine has been used for postanesthetic shivering due to possible κ-opioid receptor activity. The drug also exhibits local anesthetic effects via sodium channel blockade and can inhibit dopamine and norepinephrine reuptake, which may contribute to some stimulant properties. Due to a higher risk of side effects compared with other opioids—including serotonin syndrome, seizures, delirium, dysphoria, and tremor—its use has declined in favor of safer alternatives.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pethidine.